Impaired SARS-CoV-2 vaccine responsiveness is not associated with subclinical atherosclerosis or cardiovascular disease

Our study demonstrates that subclinical atherosclerosis or prevalent CVD is not associated with impaired responsiveness to vaccination.

Authors

Institutions

Publication Details

Journal
European Heart Journal Open
Published
2025-12-08
DOI
https://doi.org/10.1093/ehjopen/oeaf167
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impaired SARS-CoV-2 vaccine responsiveness is not associated with subclinical atherosclerosis or cardiovascular disease

Gunnar Engström, Harry Björkbacka, Megan Mulholland, Irena Ljungcrantz et al.
European Heart Journal Open
SARS-CoV-2 and COVID-19 Research
article

Impaired SARS-CoV-2 vaccine responsiveness is not associated with subclinical atherosclerosis or cardiovascular disease

Gunnar Engström, Harry Björkbacka, Megan Mulholland, Irena Ljungcrantz, Sandra Andersson, Jan Nilsson, Alexandru Șchiopu, Daniel Engelbertsen, Pernilla Katra, Linda Andersson, Anthi Chalou
article en

Abstract

Our study demonstrates that subclinical atherosclerosis or prevalent CVD is not associated with impaired responsiveness to vaccination.

European Heart Journal OpenVol. 6(1)
Malmö University (SE), Skåne University Hospital (SE), Institute of Parasitology (CZ), Walden University (US)
Openalex Percentile: Top 54%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.